Central Nervous System Depressants

DBCAT000399Therapeutic category

A very loosely defined group of drugs that tend to reduce the activity of the central nervous system. The major groups included here are ethyl alcohol, anesthetics, hypnotics and sedatives, narcotics, and tranquilizing agents (antipsychotics... A DrugBank category of 792 drugs. 448 of them are approved.

Also known as: Depressants, CNS · CNS Depressants
Drugs: 1,2-Benzodiazepine
2,5-Dimethoxy-4-ethylthioamphetamine
4-Bromo-2,5-dimethoxyphenethylamine
4-Methoxyamphetamine
5-methoxy-N,N-dimethyltryptamine
7-Nitroindazole
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
Acecarbromal
Acepromazine
Aceprometazine
Acetazolamide
Acetophenazine
Acetylglycinamide chloral hydrate
Adinazolam
Adipiplon
Afloqualone
Agomelatine
Alaproclate
Alcuronium
Alfaxalone
Alfentanil
Alimemazine
Allobarbital
Almotriptan
Alnespirone
and 767 more with a free account

What you can answer from here — as of September 15, 2022

792DrugsEach linked to its full drug card

481Drug targetsEvery drug–target pair in the class, with bond type

153,746Marketed productsAcross the regions we cover, with dosage forms and routes

67Routes of administrationHow the drugs in this class are given

9SubcategoriesNarrower classes within this one

Which targets do Central Nervous System Depressants share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account